Pharma industry concerned by broader drug data disclosure

Increased access to information submitted to the European Medicines Agency may be detrimental to drug companies, representatives of the pharma industry have said.

Efpia, the European Federation of Pharmaceutical Industries and Associations, expressed its concerns in its 31 August response to a public consultation organised by the medicines agency.